Healthcare partnerships Cordis engages in strategic collaborations such as with Premier for vascular closure devices and with Auckland Zoo for sustainability and community initiatives, indicating openness to co-development or co-marketing arrangements that could expand distribution channels or create joint value propositions in new markets.

Clinical study momentum The RADIANCY clinical study in Europe demonstrates active clinical evidence generation and potential adoption by physicians; sales opportunities exist in expanding registry enrollment, leveraging study outcomes for reimbursement discussions, and tying product benefits to improved patient outcomes.

Innovation engine Cordis emphasizes internal development plus CordisX incubator partnerships and targeted acquisitions, signaling a readiness to adopt or license disruptive technologies; this creates opportunities to position complementary devices, software, or data analytics solutions that enhance interventional care.

Legal and competitive dynamics Ongoing legal actions with Medtronic over drug-coated stents highlight a highly competitive and litigious market; sales teams should emphasize differentiated performance, clinical evidence, and total cost of ownership to navigate competitive differentiators.

Sustainability and community Sustainability partnerships and educational initiatives (Auckland Zoo collaboration; culture podcast) suggest customer segments value ESG alignment; there may be openings for services or products that reduce environmental impact, improve lifecycle management, or support physician and hospital educational programs.